Piperacillin-tazobactam-induced acute interstitial nephritis with possible meropenem cross-sensitivity in a patient with osteomyelitis

American Journal of Health-System Pharmacy

Volumn 69, Issue 13, 2012, Pages 1109-

  Liu, Tina J ^a   Lam, Joseph P ^a  

^a ALAMEDA COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GALLIUM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ACUTE KIDNEY FAILURE; ADULT; CASE REPORT; CROSS ALLERGY; DIALYSIS; DRUG WITHDRAWAL; ECHOGRAPHY; HOSPITAL INFECTION; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY FUNCTION; KIDNEY SCINTISCANNING; LETTER; MALE; OSTEOMYELITIS; PRIORITY JOURNAL; TREATMENT DURATION; URINALYSIS;

EID: 84862836672     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp120068     Document Type: Letter

References (6)

1. Neilson EG. Pathogenesis and therapy of interstitial nephritis. Kidney Int. 1989;35:1257-70.
2. Ten RM, Torres VE, Milliner DS et al. Acute interstitial nephritis: immunologic and clinical aspects. Mayo Clin Proc. 1988;63:921-30.
3. Baker RJ, Pusey CD. The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant. 2004; 19:8-11.
4. Kodner CM, Kudrimoti A. Diagnosis and management of acute interstitial nephritis. Am Fam Physician. 2003; 67:2527-39.
5. Alexopoulos E. Drug-induced acute interstitial nephritis. Ren Fail. 1998; 20:809-19.
6. Perazella MA, Markowitz GS. Druginduced acute interstitial nephritis. Nat Rev Nephrol. 2010; 6:461-70.